Mutant SOD1 increases APP expression and phosphorylation in cellular and animal models of ALS

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Rabinovich Toidman, Polina ^a   Rabinovich Nikitin, Inna ^a   Ezra, Assaf ^a   Barbiro, Beka ^a   Fogel, Hilla ^a   Slutsky, Inna ^a   Solomon, Beka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; COPPER ZINC SUPEROXIDE DISMUTASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BBS; PROTEIN P53; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; PROTEIN BINDING; SOD1 PROTEIN, HUMAN; SOD1 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIPPOCAMPUS; LIFE EXTENSION; MALE; MOUSE; MOUSE MODEL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SYNAPSE; ANIMAL; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MORTALITY; MUTATION; PHOSPHORYLATION; TRANSGENIC MOUSE;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE-1; SYNAPSES;

EID: 84963864308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143420     Document Type: Article

References (36)

1. Leigh PN. Chapter 13 Amyotrophic lateral sclerosis. Handb Clin Neurol/Ed by PJ Vinken GW Bruyn. 2007; 82: 249-78. doi: 10.1016/S0072-9752(07)80016-9
2. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006; 7: 710-23. doi: 10.1038/nrn1971 PMID: 16924260
3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994; 264: 1772-5. Available: http://www.ncbi.nlm.nih.gov/pubmed/8209258. PMID: 8209258
4. Slunt HH, Thinakaran G, Von Koch C, Lo AC, Tanzi RE, Sisodia SS. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem. 1994; 269: 2637-44. Available: http://www.ncbi.nlm.nih.gov/pubmed/8300594. PMID: 8300594
5. Zheng H, Koo EH. The amyloid precursor protein: beyond amyloid. Mol Neurodegener. 2006; 1: 5. doi: 10.1186/1750-1326-1-5 PMID: 16930452
6. Murakami N, Yamaki T, Iwamoto Y, Sakakibara T, Kobori N, Fushiki S, et al. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma. 1998; 15: 993-1003. Available: http://www.ncbi.nlm.nih.gov/pubmed/9840772. PMID: 9840772
7. Xie YY, Yao ZB, Wu WT. Survival of motor neurons and expression of beta-amyloid protein in the aged rat spinal cord. Neuroreport. 2000; 11: 697-700. Available: http://www.ncbi.nlm.nih.gov/pubmed/10757503. PMID: 10757503
8. Koistinen H, Prinjha R, Soden P, Harper A, Banner SJ, Pradat P-F, et al. Elevated levels of amyloid precursorprotein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve. 2006; 34: 444-50. doi: 10.1002/mus.20612 PMID: 16856153
9. Sasaki S, Iwata M. Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol. 1999; 97: 463-8. Available: http://www.ncbi.nlm.nih.gov/pubmed/10334483. PMID: 10334483
10. Bryson JB, Hobbs C, Parsons MJ, Bosch KD, Pandraud A, Walsh FS, et al. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2012; 21: 3871-82. doi: 10.1093/hmg/dds215 PMID: 22678056
11. Zhang H, Ma Q, Zhang Y, Xu H. Proteolytic processing of Alzheimer's β-amyloid precursor protein. J Neurochem. 2012; 120 Suppl: 9-21. doi: 10.1111/j.1471-4159.2011.07519.x
12. Ozaki T, Li Y, Kikuchi H, Tomita T, Iwatsubo T, Nakagawara A. The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem Biophys Res Commun. 2006; 351: 57-63. doi: 10.1016/j.bbrc.2006.09.162 PMID: 17054906
13. Shankar GM, Walsh DM. Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener. 2009; 4: 48. doi: 10.1186/1750-1326-4-48 PMID: 19930651
14. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol. 2002; 156: 519-29. doi: 10.1083/jcb.200110119 PMID: 11815632
15. Rabinovich-Nikitin I, Rakover IS, Becker M, Solomon B. Beneficial Effect of Antibodies against β-Secretase Cleavage Site of App on Alzheimer's-Like Pathology in Triple-Transgenic Mice. PLoS One. 2012; 7: e46650. doi: 10.1371/journal.pone.0046650 PMID: 23071606
16. Bros-Facer V, Krull D, Taylor A, Dick JRT, Bates S a., Cleveland MS, et al. Treatment with an antibody directed against nogo-a delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Hum Mol Genet. 2014; 23: 4187-4200. doi: 10.1093/hmg/ddu136 PMID: 24667415
17. Liu H-T, Tashmukhamedov BA, Inoue H, Okada Y, Sabirov RZ. Roles of two types of anion channels in glutamate release from mouse astrocytes under ischemic or osmotic stress. Glia. 2006; 54: 343-57. doi: 10.1002/glia.20400 PMID: 16883573
18. Arbel M, Yacoby I, Solomon B. Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. Proc Natl Acad Sci U S A. 2005; 102: 7718-23. doi: 10.1073/pnas.0502427102 PMID: 15894613
19. Mali Y, Zisapel N. A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model. J Med Chem. 2009; 52: 5442-8. doi: 10.1021/jm900631m PMID: 19670830
20. Qiu WQ, Ferreira A, Miller C, Koo EH, Selkoe DJ. Cell-surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. J Neurosci. 1995; 15: 2157-2167. PMID: 7891158
21. Laviv T, Riven I, Dolev I, Vertkin I, Balana B, Slesinger PA, et al. Basal GABA regulates GABA(B)R conformation and release probability at single hippocampal synapses. Neuron. 2010; 67: 253-67. doi: 10.1016/j.neuron.2010.06.022 PMID: 20670833
22. Lee M-S, Kao S-C, Lemere CA, Xia W, Tseng H-C, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003; 163: 83-95. doi: 10.1083/jcb.200301115 PMID: 14557249
23. Fogel H, Frere S, Segev O, Bharill S, Shapira I, Gazit N, et al. APP homodimers transduce an amyloid-β-mediated increase in release probability at excitatory synapses. Cell Rep. 2014; 7: 1560-76. doi: 10.1016/j.celrep.2014.04.024 PMID: 24835997
24. Ranganathan S, Bowser R. p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. Open Pathol J. 2010; 4: 11-22. doi: 10.2174/1874375701004010011 PMID: 21572928
25. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001; 57: 1282-9. Available: http://www.ncbi.nlm.nih.gov/pubmed/11591849. PMID: 11591849
26. Lee M-S, Kao S-C, Lemere CA, Xia W, Tseng H-C, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003; 163: 83-95. doi: 10.1083/jcb.200301115 PMID: 14557249
27. Chang K-A, Kim H-S, Ha T-Y, Ha J-W, Shin KY, Jeong YH, et al. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol. 2006; 26: 4327-38. doi: 10.1128/MCB.02393-05 PMID: 16705182
28. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010; 11: 303-311. doi: 10.3109/17482961003727954 PMID: 20433413
29. Coan G, Mitchell CS. An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies. Neurodegener Dis. 2015; 15: 301-312. doi: 10.1159/000433581 PMID: 26183171
30. Pardossi-Piquard R, Checler F. The physiology of the β-amyloid precursor protein intracellular domain AICD. J Neurochem. 2012; 120 Suppl: 109-24. doi: 10.1111/j.1471-4159.2011.07475.x
31. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci. 2004; 117: 4435-48. doi: 10.1242/jcs.01323 PMID: 15331662
32. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, et al. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem. 2001; 268: 5329-36. Available: http://www.ncbi.nlm.nih.gov/pubmed/11606195. PMID: 11606195
33. Martin LJ. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol Dis. 2000; 7: 613-22. doi: 10.1006/nbdi.2000.0314 PMID: 11114260
34. Li Q-X, Mok SS, Laughton KM, McLean C a, Volitakis I, Cherny R a, et al. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Aging Cell. 2006; 5: 153-65. doi: 10.1111/j.1474-9726.2006.00200.x PMID: 16626394
35. Hall ED, Oostveen J a, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998; 23: 249-56. Available: http://www.ncbi.nlm.nih.gov/pubmed/9633809. PMID: 9633809
36. Rabinovich-Toidman P, Becker M, Barbiro B, Solomon B. Inhibition of amyloid precursor protein beta-secretase cleavage site affects survival and motor functions of amyotrophic lateral sclerosis transgenic mice. Neurodegener Dis. 2012; 10: 30-3. doi: 10.1159/000334774 PMID: 22269310